Table 1. Patient characteristics.
| Demographic data (n=75) | ||
|---|---|---|
| Mean age in years (±s.d.) |
60±13 |
|
| Median tumour size in cm (min, max) |
1.7 (0.7, 10) |
|
|
Tumour size |
n |
% |
| T1a |
0 |
0 |
| T1b |
5 |
6.7 |
| T1c |
44 |
58.7 |
| T2 |
21 |
28 |
| T3 |
5 |
6.7 |
| Invasive ductal carcinoma |
60 |
80 |
| Invasive lobular carcinoma |
13 |
17.3 |
| Invasive mucinous carcinoma |
2 |
2.7 |
|
Grading | ||
| G1 |
27 |
36 |
| G2 |
40 |
53.3 |
| G3 |
8 |
10.7 |
|
Lymph nodes | ||
| N0 |
48 |
64 |
| N1 |
20 |
26.7 |
| N2/N3 |
7 |
9.3 |
| PVI |
22 |
29.3 |
| ER+ |
74 |
98.7 |
| Her2neu+ |
1 |
1.3 |
|
Ki-67 | ||
| 10% |
26 |
34.7 |
| 15–25% |
27 |
36 |
| >30% |
22 |
29.3 |
| MammaPrint high risk |
18 |
24 |
| MammaPrint low risk |
57 |
76 |
| Luminal |
73 |
97.3 |
| Basal |
1 |
1.3 |
| ERB2 | 1 | 1.3 |
Abbreviations: ER=oestrogen receptor; PVI=perivascular invasion.